Wealthcare Advisory Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
MCMC
CC
Wealthcare Advisory Partners's CDNA Position: Q2 2021 in Review
Wealthcare Advisory Partners sold out of CareDx (CDNA) in Q2 2021, closing a stake of 90 shares — an estimated $6K sold.
Wealthcare Advisory Partners first reported a position in CDNA in Q1 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.
- Wealthcare Advisory Partners reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
- Wealthcare Advisory Partners sold 90 CareDx shares in Q2 2021, an estimated $6K.
- Wealthcare Advisory Partners first reported a position in CareDx in Q1 2020 and held it in 2 quarters.
- Wealthcare Advisory Partners's CareDx position peaked at $6K in Q1 2021.
- 254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.